VINEETLAB

Vineet Laboratories Limited

Active Pharmaceutical Ingredient Intermediates manufacturer

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

vineetlabs.co.in(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹39.01
Market cap
75 Cr
Stock P/E
46.7
P/B
1.64
Dividend yield
1.2%
ROE (FY26)
3.5%
ROCE (FY26)
7.5%
Operating margin (FY26)
10.2%
Debt / equity (FY26)
0.99
OCF / EBITDA (FY26)
-144.4%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Vineet Laboratories is a small Hyderabad-based pharmaceutical manufacturer that sells manufactured products and some services to customers in India.

Company snapshot

114thBy market cap

Ranked among 119 companies in Pharmaceuticals.

What we see

Concerns
  • ✗Net margin is very thin at 2.7% — little room for error if costs rise.
2 more signals from the filings.Sign in free to see them all

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Standalone only

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales38 Cr43 Cr33 Cr37 Cr24 Cr19 Cr18 Cr14 Cr7 Cr17 Cr16 Cr19 Cr
Operating expenses (approx.)37 Cr39 Cr33 Cr34 Cr25 Cr19 Cr22 Cr25 Cr7 Cr14 Cr13 Cr16 Cr
EBITDA0.26 Cr4 Cr-0.64 Cr3 Cr-0.80 Cr-0.31 Cr-4 Cr-11 Cr0.32 Cr3 Cr2 Cr2 Cr
OPM %0.7%9.6%-2.0%9.2%-3.3%-1.6%-22.9%-78.5%4.3%18.2%15.9%13.2%
Other income0.03 Cr0.01 Cr0.01 Cr0.41 Cr0.37 Cr0.20 Cr0.03 Cr1 Cr0.02 Cr0.0084 Cr0.05 Cr0.03 Cr
Interest0.96 Cr1 Cr1 Cr2 Cr1 Cr0.99 Cr0.95 Cr0.90 Cr0.61 Cr2 Cr1 Cr0.99 Cr
Depreciation0.61 Cr0.61 Cr0.63 Cr0.67 Cr0.61 Cr0.62 Cr0.62 Cr0.66 Cr0.63 Cr0.63 Cr0.63 Cr0.54 Cr
Profit before tax-1 Cr3 Cr-2 Cr1 Cr-2 Cr-2 Cr-6 Cr-11 Cr-0.90 Cr0.37 Cr0.82 Cr2 Cr
Tax %2.5%4.9%11.4%-34.2%1.7%-6.8%-0.6%6.2%3.9%-7.9%-4.0%26.3%
Net profit-1 Cr2 Cr-2 Cr2 Cr-2 Cr-2 Cr-6 Cr-11 Cr-0.87 Cr0.40 Cr0.85 Cr1 Cr
EPS (₹)₹-1.36₹2.62₹-2.24₹2.09₹-2.31₹-1.98₹-6.19₹-11.42₹-0.94₹0.43₹0.92₹0.43

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales243 Cr191 Cr212 Cr151 Cr75 Cr59 CrSign in free for the trailing twelve months
Operating expenses (approx.)235 Cr178 Cr205 Cr143 Cr91 Cr51 CrSign in free for the trailing twelve months
EBITDA8 Cr13 Cr8 Cr7 Cr-16 Cr8 CrSign in free for the trailing twelve months
OPM %3.3%6.9%3.6%4.8%-21.7%14.3%Sign in free for the trailing twelve months
Other income0.39 Cr0.29 Cr0.12 Cr0.46 Cr2 Cr0.10 CrSign in free for the trailing twelve months
Interest3 Cr2 Cr3 Cr5 Cr4 Cr5 CrSign in free for the trailing twelve months
Depreciation2 Cr2 Cr2 Cr3 Cr3 Cr2 CrSign in free for the trailing twelve months
Profit before tax4 Cr9 Cr2 Cr0.36 Cr-21 Cr2 CrSign in free for the trailing twelve months
Tax %56.1%29.0%38.3%-182.6%2.8%17.4%Sign in free for the trailing twelve months
Net profit2 Cr7 Cr1 Cr1 Cr-20 Cr2 CrSign in free for the trailing twelve months
EPS (₹)₹2.18₹7.16₹1.36₹1.11₹-21.90₹1.00Sign in free for the trailing twelve months
Dividend payout %0.0%0.0%73.6%0.0%—0.0%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital9 Cr9 Cr9 Cr9 Cr9 Cr19 Cr
Reserves17 Cr24 Cr24 Cr26 Cr5 Cr26 Cr
Borrowings12 Cr27 Cr31 Cr44 Cr40 Cr45 Cr
Other liabilities70 Cr74 Cr51 Cr38 Cr40 Cr34 Cr
Total liabilities109 Cr134 Cr116 Cr117 Cr95 Cr125 Cr
Fixed assets (net)20 Cr21 Cr27 Cr27 Cr25 Cr24 Cr
CWIP0 Cr0 Cr0 Cr——0 Cr
Investments0.12 Cr0.14 Cr0.13 Cr0.18 Cr0.21 Cr0.19 Cr
Loans & advances0 Cr0 Cr0 Cr0.06 Cr0 Cr0 Cr
Inventories40 Cr44 Cr46 Cr49 Cr50 Cr64 Cr
Trade receivables43 Cr40 Cr35 Cr32 Cr13 Cr11 Cr
Cash & bank0.75 Cr17 Cr0.63 Cr0.23 Cr0.31 Cr17 Cr
Other assets6 Cr12 Cr7 Cr8 Cr5 Cr8 Cr
Total assets109 Cr134 Cr116 Cr117 Cr95 Cr125 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity-9 Cr8 Cr-10 Cr-11 Cr11 Cr-12 Cr
Cash from investing-8 Cr-4 Cr-7 Cr0.33 Cr-3 Cr-1 Cr
Cash from financing19 Cr12 Cr0.27 Cr11 Cr-8 Cr30 Cr
Net cash flow2 Cr16 Cr-16 Cr-0.40 Cr0.08 Cr16 Cr
Free cash flow (OCF − Capex)-17 Cr4 Cr-17 Cr-12 Cr10 Cr-13 Cr

Ratios

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %17.2%19.3%8.4%6.5%-30.7%7.5%
ROE %6.7%20.0%3.7%3.0%-137.8%3.5%
Debtor days647760776470
Inventory days75105100137285377
Days payable1061447689192149
Cash conversion cycle333785124158298
OCF / EBITDA %-107.0%58.3%-125.5%-158.7%—-144.4%
OCF / EBITDA % (3 years)——-36.5%-47.4%——
Debt / equity0.470.800.921.282.730.99
Current ratio1.161.121.171.160.911.47
Net debt / EBITDA1.440.743.986.12—3.38